Atherid Therapeutics

THE ATHERID SOLUTION
We are developing the first drug to clear cholesterol and other lipids from the walls of arteries. Our drug is based on a naturally occurring protein linked to a smaller molecule which targets it to the plaques. Preclinical studies have shown it to be safe and reduce plaques from blood vessels via a unique mechanism. After 10 years of extensive testing in mice and on human tissue taken from surgery, we are ready to complete final preclinical studies, aiming to commence trials within 2 years.

Nedlands WA 6009